Scott R. Floyd, Ph.D. - Publications

Affiliations: 
2015- Radiation Oncology Duke University, Durham, NC 
Area:
DNA damage, brain tumors
Website:
https://radonc.duke.edu/research/floyd-lab

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Stehn JR, Floyd SR, Wilker EW, Reinhardt HC, Clarke SM, Huang Q, Polakiewicz RD, Sonenberg N, Kong YW, Yaffe MB. MAPKAP Kinase-2 phosphorylation of PABPC1 controls its interaction with 14-3-3 proteins after DNA damage: A combined kinase and protein array approach. Frontiers in Molecular Biosciences. 10: 1148933. PMID 37091863 DOI: 10.3389/fmolb.2023.1148933  0.483
2021 Ge J, Ngo LP, Kaushal S, Tay IJ, Thadhani E, Kay JE, Mazzucato P, Chow DN, Fessler JL, Weingeist DM, Sobol RW, Samson LD, Floyd SR, Engelward BP. CometChip enables parallel analysis of multiple DNA repair activities. Dna Repair. 106: 103176. PMID 34365116 DOI: 10.1016/j.dnarep.2021.103176  0.778
2020 Edwards DS, Maganti R, Tanksley JP, Luo J, Park JJH, Balkanska-Sinclair E, Ling J, Floyd SR. BRD4 Prevents R-Loop Formation and Transcription-Replication Conflicts by Ensuring Efficient Transcription Elongation. Cell Reports. 32: 108166. PMID 32966794 DOI: 10.1016/j.celrep.2020.108166  0.65
2020 Tay IJ, Park JJH, Price AL, Engelward BP, Floyd SR. HTS-Compatible CometChip Enables Genetic Screening for Modulators of Apoptosis and DNA Double-Strand Break Repair. Slas Discovery : Advancing Life Sciences R & D. 2472555220918367. PMID 32452708 DOI: 10.1177/2472555220918367  0.777
2020 Moravan MJ, Fecci PE, Anders CK, Clarke JM, Salama AKS, Adamson JD, Floyd SR, Torok JA, Salama JK, Sampson JH, Sperduto PW, Kirkpatrick JP. Current multidisciplinary management of brain metastases. Cancer. PMID 31971613 DOI: 10.1002/Cncr.32714  0.311
2019 Nehama D, Di Ianni N, Musio S, Du H, Patané M, Pollo B, Finocchiaro G, Park JJH, Dunn DE, Edwards DS, Damrauer JS, Hudson H, Floyd SR, Ferrone S, Savoldo B, et al. B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres. Ebiomedicine. PMID 31466914 DOI: 10.1016/J.Ebiom.2019.08.030  0.711
2019 Satterlee A, Dunn D, Floyd S, Hingtgen S. SCIDOT-20. ADAPTING ENGINEERED CELL THERAPIES TO UNDERSTAND AND OVERCOME GLIOBLASTOMA RESISTANCE USING INTEGRATED IN VIVO AND EX VIVO MODELS Neuro-Oncology. 21: vi275-vi275. DOI: 10.1093/Neuonc/Noz175.1156  0.322
2018 Lam FC, Morton SW, Wyckoff J, Vu Han TL, Hwang MK, Maffa A, Balkanska-Sinclair E, Yaffe MB, Floyd SR, Hammond PT. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles. Nature Communications. 9: 1991. PMID 29777137 DOI: 10.1038/S41467-018-04315-4  0.744
2018 Lam F, Morton S, Wyckoff J, Vu Han T, Hwang M, Maffa A, Balkanska-Sinclair E, Yaffe M, Floyd S, Hammond P. CADD-03. A VERSATILE AND MODULAR TARGETED NANOPARTICLE PLATFORM FOR DELIVERY OF COMBINATION THERAPIES TO ADULT AND PEDIATRIC CNS TUMORS Neuro-Oncology. 20: vi277-vi277. DOI: 10.1093/Neuonc/Noy148.1152  0.729
2017 Jimenez RB, Alexander BM, Mahadevan A, Niemierko A, Rajakesari S, Arvold ND, Floyd SR, Oh KS, Loeffler JS, Shih HA. The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity. Advances in Radiation Oncology. 2: 391-397. PMID 29114607 DOI: 10.1016/J.Adro.2017.05.008  0.314
2017 Lam F, Morton S, Wyckoff J, Maffa A, Balkanska-Sinclair E, Floyd S, Hammond P. EXTH-03. ENHANCED IN VIVO EFFICACY AND SAFETY OF COMBINATION TEMOZOLOMIDE AND BROMODOMAIN INHIBITOR THERAPY FOR GLIOMAS USING A TARGETED DUAL DRUG-LOADING STEALTH LIPOSOMAL CARRIER Neuro-Oncology. 19: vi73-vi73. DOI: 10.1093/Neuonc/Nox168.299  0.731
2016 Huynh MA, Maire CL, Abazeed M, Lam FC, Adams D, Pelton K, Pinnell N, Knoff DC, Korideck H, Hummelen PV, Thorner A, Wen PY, Ligon A, Floyd SR, Schreiber SL, et al. Functional profiling of a glioblastoma (GBM) patient-derived cell line (PDCL) panel to identify cell-intrinsic differential radiation response. Journal of Clinical Oncology. 34: 2069-2069. DOI: 10.1200/Jco.2016.34.15_Suppl.2069  0.305
2015 Rameseder J, Krismer K, Dayma Y, Ehrenberger T, Hwang MK, Airoldi EM, Floyd SR, Yaffe MB. A Multivariate Computational Method to Analyze High-Content RNAi Screening Data. Journal of Biomolecular Screening. PMID 25918037 DOI: 10.1177/1087057115583037  0.764
2015 Mahadevan A, Barron L, Floyd SR, Kasper E, Wong ET. Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas. Journal of Clinical Oncology. 33: e13036-e13036. DOI: 10.1200/Jco.2015.33.15_Suppl.E13036  0.304
2013 Floyd SR, Pacold ME, Huang Q, Clarke SM, Lam FC, Cannell IG, Bryson BD, Rameseder J, Lee MJ, Blake EJ, Fydrych A, Ho R, Greenberger BA, Chen GC, Maffa A, et al. The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature. 498: 246-50. PMID 23728299 DOI: 10.1038/Nature12147  0.778
2013 Weingeist DM, Ge J, Wood DK, Mutamba JT, Huang Q, Rowland EA, Yaffe MB, Floyd S, Engelward BP. Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitors. Cell Cycle (Georgetown, Tex.). 12: 907-15. PMID 23422001 DOI: 10.4161/Cc.23880  0.595
2013 Greenberger B, Pacold M, Tay J, Alter R, Huang Q, Ge J, Bradner J, Engelward B, Yaffe M, Floyd S. Characterizing Cell-Specific Radiation Sensitization Induced by HDAC Inhibition International Journal of Radiation Oncology*Biology*Physics. 87: S627-S628. DOI: 10.1016/J.Ijrobp.2013.06.1659  0.499
2012 Fonkem E, Uhlmann EJ, Floyd SR, Mahadevan A, Kasper E, Eton O, Wong ET. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Expert Review of Neurotherapeutics. 12: 1207-15. PMID 23082737 DOI: 10.1586/Ern.12.111  0.316
2011 Mahadevan A, Floyd S, Wong E, Chen C, Kasper E. Clinical outcome after Hypofractionated Stereotactic Radiotherapy (HSRT) for benign skull base tumors Computer Aided Surgery. 16: 112-120. PMID 21466421 DOI: 10.3109/10929088.2011.565160  0.302
2009 Bubley G, Huang Q, Lee M, Floyd S, Jones G, Yaffe M. Abstract B147: Lack of an additive effect of radiation treatment on PI3K or mTOR inhibition in prostate cancer cell lines Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B147  0.509
2009 Pacold M, Blake E, Clarke S, Fydrych A, West N, Bradner J, Yaffe M, Floyd S. A Combined Small Molecule and shRNA High-content Screen of Chromatin Modifiers Identifies an Acetyl-lysine Binding Protein as a Suppressor of the DNA Damage Response to Ionizing Radiation International Journal of Radiation Oncology*Biology*Physics. 75: S534. DOI: 10.1016/J.Ijrobp.2009.07.1219  0.564
2008 Floyd S, Pacold M, Blake E, Sabatini D, Yaffe M. A High Throughput Automated Microscopy RNAi Screen for Modifiers of the DNA Damage Response to Ionizing Radiation International Journal of Radiation Oncology*Biology*Physics. 72: S692-S693. DOI: 10.1016/J.Ijrobp.2008.06.588  0.557
2006 Floyd S, Stehn J, Wilker E, Yaffe M. 2656 International Journal of Radiation Oncology*Biology*Physics. 66: S574-S575. DOI: 10.1016/J.Ijrobp.2006.07.1071  0.481
2002 Schmierer K, Grosse P, De Camilli P, Solimena M, Floyd S, Zschenderlein R. Paraneoplastic stiff-person syndrome: no tumor progression over 5 years. Neurology. 58: 148. PMID 11781426 DOI: 10.1212/Wnl.58.1.148  0.43
2001 Farsad K, Ringstad N, Takei K, Floyd SR, Rose K, De Camilli P. Generation of high curvature membranes mediated by direct endophilin bilayer interactions. The Journal of Cell Biology. 155: 193-200. PMID 11604418 DOI: 10.1083/Jcb.200107075  0.738
2001 Floyd SR, Porro EB, Slepnev VI, Ochoa GC, Tsai LH, De Camilli P. Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2. The Journal of Biological Chemistry. 276: 8104-10. PMID 11113134 DOI: 10.1074/Jbc.M008932200  0.639
1999 Ferracci F, Fassetta G, Butler MH, Floyd S, Solimena M, De Camilli P. A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer. Neurology. 53: 852-5. PMID 10489053 DOI: 10.1212/Wnl.53.4.852  0.448
1998 Floyd S, De Camilli P. Endocytosis proteins and cancer: a potential link? Trends in Cell Biology. 8: 299-301. PMID 9704404 DOI: 10.1016/S0962-8924(98)01316-6  0.464
1998 Floyd S, Butler MH, Cremona O, David C, Freyberg Z, Zhang X, Solimena M, Tokunaga A, Ishizu H, Tsutsui K, De Camilli P. Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer. Molecular Medicine (Cambridge, Mass.). 4: 29-39. PMID 9513187 DOI: 10.1007/Bf03401727  0.452
Show low-probability matches.